Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma

References

• MiyazakiJNishiyamaHEpidemiology of urothelial carcinomaInt J Urol2017241073073428543959
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer NetworkClinical Practice Guidelines in Oncology: bladder cancer, version 52017 Available from: NCCN.orgAccessed December 13, 2017
   Google Scholar
• PommerWBronderEKlimpelAHelmertUGreiserEMolzahnMUrothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer StudyNephrol Dial Transplant199914122892289710570093
   PubMed Web of Science ®Google Scholar
• McLaughlinJKSilvermanDTHsingAWCigarette smoking and cancers of the renal pelvis and ureterCancer Res19925222542571728398
   PubMed Web of Science ®Google Scholar
• ReulenRCKellenEBuntinxFBrinkmanMZeegersMPA meta-analysis on the association between bladder cancer and occupationScand J Urol Nephrol2008422186478
   Google Scholar
• MostafaMHSheweitaSAO’ConnorPJRelationship between schistosomiasis and bladder cancerClin Microbiol Rev1999121971119880476
   PubMed Web of Science ®Google Scholar
• YanHXieHYingYPioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysisCancer Manag Res2018101627163829970962
   PubMed Web of Science ®Google Scholar
• TurnerRMKwokCSChen-TurnerCMaduakorCASinghSLokeYKThiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysisBr J Clin Pharmacol201478225827324325197
   PubMed Web of Science ®Google Scholar
• BabjukMBurgerMZigeunerREuropean Association of UrologyEAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013Eur Urol201364463965323827737
   PubMed Web of Science ®Google Scholar
• MiyakeMFujimotoKHiraoYActive surveillance for nonmuscle invasive bladder cancerInvestig Clin Urol201657Suppl 1S4S13
   Web of Science ®Google Scholar
• MiyakeMGotohDShimadaKExploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: long-term follow-up experience at a single instituteInt J Urol201522654154725857336
   PubMed Web of Science ®Google Scholar
• SuganoKKakizoeTGenetic alterations in bladder cancer and their clinical applications in molecular tumor stagingNat Clin Pract Urol200631264265217149381
   PubMedGoogle Scholar
• SylvesterRJvan der MeijdenAPOosterlinckWPredicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trialsEur Urol200649346647716442208
   PubMed Web of Science ®Google Scholar
• Fernandez-GomezJSolsonaEUndaMClub Urológico Español de Tratamiento Oncológico (CUETO)Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trialsEur Urol2008535992100217950987
   PubMed Web of Science ®Google Scholar
• MiyakeMMorizawaYHoriSClinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladderBMC Cancer201717123728359307
   PubMed Web of Science ®Google Scholar
• MiyakeMMorizawaYHoriSIntegrative assessment of pretreatment inflammation-, nutrition-, and muscle-based prognostic markers in patients with muscle-invasive bladder cancer undergoing radical cystectomyOncology201793425926928647740
   PubMed Web of Science ®Google Scholar
• MorizawaYMiyakeMShimadaKNeutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomyUrol Oncol2016346257.e117
   Web of Science ®Google Scholar
• LeeDJChangSSCost considerations in the management of bladder cancerUrol Times Available from: http://www.urologytimes.com/modern-medicine-feature-articles/cost-considerationsmanagement-bladder-cancerAccessed October 16, 2017
   Google Scholar
• MariottoABYabroffKRShaoYFeuerEJBrownMLProjections of the cost of cancer care in the United States: 2010-2020J Natl Cancer Inst2011103211712821228314
   PubMed Web of Science ®Google Scholar
• HubenRPMounzerAMMurphyGPTumor grade and stage as prognostic variables in upper tract urothelial tumorsCancer1988629201620203167813
   PubMed Web of Science ®Google Scholar
• CattoJWHartmannAStoehrRMultifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearanceJ Urol200617562323233016697867
   PubMed Web of Science ®Google Scholar
• CattoJWYatesDRRehmanIBehavior of urothelial carcinoma with respect to anatomical locationJ Urol200717751715172017437794
   PubMed Web of Science ®Google Scholar
• RamanJDMesserJSielatyckiJAHollenbeakCSIncidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005BJU Int201110771059106420825397
   PubMed Web of Science ®Google Scholar
• RouprêtMBabjukMCompératEEuropean association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 updateEur Urol201568586887926188393
   PubMed Web of Science ®Google Scholar
• MiyakeMTatsumiYFujimotoKNishinipon Uro-Oncology Collaborative GroupChanges in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative studyJpn J Clin Oncol201646121148115527576438
   PubMed Web of Science ®Google Scholar
• RinkMEhdaieBChaEKBladder Cancer Research Consortium (BCRC); Upper Tract Urothelial Carcinoma Collaboration (UTUCC)Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgeryEur Urol201262467768422349570
   PubMed Web of Science ®Google Scholar
• MargulisVShariatSFMatinSFUpper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma CollaborationOutcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma CollaborationCancer200911561224123319156917
   PubMed Web of Science ®Google Scholar
• LiCCChangTHWuWJSignificant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patientsEur Urol20085451127113418243511
   PubMed Web of Science ®Google Scholar
• NovaraGde MarcoVGottardoFIndependent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centersCancer200711081715172217724728
   PubMed Web of Science ®Google Scholar
• BlickCGNazirSAMallettSEvaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinicBJU Int20121101849422122739
   PubMed Web of Science ®Google Scholar
• YafiFABrimoFSteinbergJAprikianAGTanguaySKassoufWProspective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancerUrol Oncol201533266.e2531
   Web of Science ®Google Scholar
• McCroskeyZPambuccianSEKleithermsSAccuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimensAm J Clin Pathol2015144690290826572997
   PubMed Web of Science ®Google Scholar
• MiyakeMMorizawaYHoriSDiagnostic and prognostic role of urinary collagens in primary human bladder cancerCancer Sci2017108112221222828837258
   PubMed Web of Science ®Google Scholar
• HeHHanCHaoLZangGImmunoCyt test compared to cytology in the diagnosis of bladder cancer: a meta-analysisOncol Lett2016121838827347104
   PubMed Web of Science ®Google Scholar
• HajdinjakTUroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testingUrol Oncol200826664665118367109
   PubMed Web of Science ®Google Scholar
• GalvánABSalidoMEspinetBA multicolor fluorescence in situ hybridization assay: a monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: a prospective studyCancer Cytopathol2011119639540321717592
   PubMed Web of Science ®Google Scholar
• KojimaTNishiyamaHOzonoSClinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in JapanInt J Clin Oncol20182361140114729971622
   PubMed Web of Science ®Google Scholar
• KimPHSukhuRCordonBHReflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopyBJU Int2014114335435924128299
   PubMed Web of Science ®Google Scholar
• KippBRKarnesRJBrankleySMMonitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridizationJ Urol2005173240140415643180
   PubMed Web of Science ®Google Scholar
• SavicSZlobecIThalmannGNThe prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical bacillus Calmette-Guérin therapyInt J Cancer2009124122899290419230026
   PubMed Web of Science ®Google Scholar
• SchubertTRauschSFahmyOGakisGStenzlAOptical improvements in the diagnosis of bladder cancer: implications for clinical practiceTher Adv Urol201791125126029662543
   PubMed Web of Science ®Google Scholar
• MiyakeMNakaiYAnaiSDiagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancerCancer Sci2014105561662224602011
   PubMed Web of Science ®Google Scholar
• NakaiYOzawaTMizunoFSpectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urineJ Cancer Res Clin Oncol2017143112309231628726046
   PubMed Web of Science ®Google Scholar
• HatzichristodoulouGKüblerHSchwaiboldHNuclear matrix protein 22 for bladder cancer detection: comparative analysis of the BladderChek® and ELISAAnticancer Res201232115093509723155286
   PubMed Web of Science ®Google Scholar
• MowattGZhuSKilonzoMSystematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancerHealth Technol Assess20101441331
   Web of Science ®Google Scholar
• SarosdyMFHudsonMAEllisWJImproved detection of recurrent bladder cancer using the Bard BTA stat TestUrology19975033493539301696
   PubMed Web of Science ®Google Scholar
• Gutiérrez BañosJLMartín GarcíaBHernández RodríguezRUsefulness of BTA Stat test (Bard) in the diagnosis of bladder cancer. Preliminary results and comparison with cytology and cystoscopyArch Esp Urol19985187787829859583
   PubMedGoogle Scholar
• D’CostaJJGoldsmithJCWilsonJSBryanRTWardDGA systematic review of the diagnostic and prognostic value of urinary protein biomarkers in urothelial bladder cancerBladder Cancer20162330131727500198
   PubMed Web of Science ®Google Scholar
• MiyakeMMorizawaYHoriSDiagnostic and prognostic role of urinary collagens in primary human bladder cancerCancer Sci2017108112221222828837258
   PubMed Web of Science ®Google Scholar
• RosserCJChangMDaiYUrinary protein biomarker panel for the detection of recurrent bladder cancerCancer Epidemiol Biomarkers Prev20142371340134524714076
   PubMed Web of Science ®Google Scholar
• ShimizuYFuruyaHBryant GreenwoodPA multiplex immunoassay for the non-invasive detection of bladder cancerJ Transl Med20161413126830497
   PubMed Web of Science ®Google Scholar
• MiyakeMSuganoKSuginoHFibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancerCancer Sci2010101125025819843069
   PubMed Web of Science ®Google Scholar
• KandimallaRMasiusRBeukersWA 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urineClin Cancer Res201319174760476923842048
   PubMed Web of Science ®Google Scholar
• GuancialEAWernerLBellmuntJFGFR3 expression in primary and metastatic urothelial carcinoma of the bladderCancer Med20143483584424846059
   PubMed Web of Science ®Google Scholar
• RossJSWangKAl-RohilRNAdvanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapyMod Pathol201427227128023887298
   PubMed Web of Science ®Google Scholar
• TomlinsonDCBaldoOHarndenPKnowlesMAFGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancerJ Pathol20072131919817668422
   PubMed Web of Science ®Google Scholar
• ZuiverloonTCvan der AaMNvan der KwastTHFibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancerClin Cancer Res201016113011301820404005
   PubMed Web of Science ®Google Scholar
• FernandezCAMillhollandJMZwarthoffECFeldmanASKarnesRJShuberAPA noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patientsRes Rep Urol20124172624199176
   PubMedGoogle Scholar
• RoperchJPGrandchampBDesgrandchampsFPromoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancerBMC Cancer201616170427586786
   PubMed Web of Science ®Google Scholar
• O’SullivanPSharplesKDalphinMA multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuriaJ Urol2012188374174722818138
   PubMed Web of Science ®Google Scholar
• LotanYOʼSullivanPRamanJDClinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinomaUrol Oncol2017358531.e15531.e22
   Web of Science ®Google Scholar
• KavalierisLO’SullivanPFramptonCPerformance characteristics of a multigene urine biomarker test for monitoring for recurrent urothelial carcinoma in a multicenter studyJ Urol201719761419142627986532
   PubMed Web of Science ®Google Scholar
• van ValenbergFJPBridgeJAMayneDValidation of a mRNA-based urine test for bladder cancer detection in patients with hematuriaEur Urol Suppl2017163e190e191
   Google Scholar
• PichlerRFritzJTulchinerGIncreased accuracy of a novel mRNA-based urine test for bladder cancer surveillanceBJU Int20181211293728941000
   PubMed Web of Science ®Google Scholar
• GazzanigaPGradiloneAde BerardinisEPrognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a Cell-Search analysisAnn Oncol20122392352235622351740
   PubMed Web of Science ®Google Scholar
• RinkMChunFKMinnerSDetection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancerBJU Int2011107101668167520735381
   PubMed Web of Science ®Google Scholar
• MsaouelPKoutsilierisMDiagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysisBMC Cancer201111133621816094
   PubMed Web of Science ®Google Scholar
• LoddeMMianCWienerHHaitelAPychaAMarbergerMDetection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary reportUrology200158336236611549481
   PubMed Web of Science ®Google Scholar
• ChenGLEl-GabryEABagleyDHSurveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysisJ Urol200016461901190411061876
   PubMed Web of Science ®Google Scholar
• BierSHennenlotterJEsserMPerformance of urinary markers for detection of upper tract urothelial carcinoma: is upper tract urine more accurate than urine from the bladder?Dis Markers201820184582387029651327
   PubMed Web of Science ®Google Scholar
• Marín-AguileraMMengualLRibalMJUtility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinomaEur Urol200751240941517010508
   PubMed Web of Science ®Google Scholar
• CoskunerECevikIOzkanADillioglugilOAkdasAIn the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumorsInt Urol Nephrol201244379379822371126
   PubMed Web of Science ®Google Scholar
• WalshIKKeanePFIshakLMFlesslandKAThe BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinomaUrology200158453253511597532
   PubMed Web of Science ®Google Scholar
• TaoJYangXLiPIdentification of circulating microRNA signatures for upper tract urothelial carcinoma detectionMol Med Rep20151256752676026323574
   PubMed Web of Science ®Google Scholar
• KriebelSSchmidtDHoldenriederSAnalysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancerPLoS One2015101e011728425629698
   PubMed Web of Science ®Google Scholar
• MontalboRIzquierdoLIngelmo-TorresMPrognostic value of circulating microRNAs in upper tract urinary carcinomaOncotarget2018924166911670029682178
   PubMedGoogle Scholar
• ChangWSLiaoCHHsuCMSignificant association of cyclooxygenase 2 genotypes with upper tract urothelial cancerAnticancer Res20153552725273025964551
   PubMed Web of Science ®Google Scholar
• ChangWSLinSSLiFJSignificant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancerAnticancer Res201333114907491224222128
   PubMed Web of Science ®Google Scholar
• LinHHKeHLHsiaoKHPotential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in TaiwanChin J Physiol201154319620221789902
   PubMed Web of Science ®Google Scholar
• LinHHHlKHsiaoKHCCND1 1722 polymorphism and potential relevance to upper tract urothelial cancerAnticancer Res20113131043104721498736
   PubMed Web of Science ®Google Scholar
• WangKLiuTGeNTERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCROncotarget2014523124281243925474136
   PubMedGoogle Scholar
• Monteiro-ReisSLeçaLAlmeidaMAccurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylationEur J Cancer201450122623324100025
   PubMed Web of Science ®Google Scholar
• GuoRQXiongGYYangKWDetection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: a prospective, single-center studyUrol Oncol2018367342.e15342.e23
   Web of Science ®Google Scholar
• BagrodiaAChaEKSfakianosJPCollaboratorsGenomic biomarkers for the prediction of stage and prognosis of upper tract urothelial carcinomaJ Urol201619561684168926778714
   PubMed Web of Science ®Google Scholar
• LyleSRHsiehCCFernandezCAShuberAPMolecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosisRes Rep Urol20124656924199183
   PubMedGoogle Scholar
• SilverbergDMUrothelial carcinoma of the upper urinary tract diagnosed via FGFR3 mutation detection in urine: a case reportBMC Urol20121212022873290
   PubMed Web of Science ®Google Scholar
• AgarwalNPalSKHahnAWCharacterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNACancer2018124102115212429517810
   PubMed Web of Science ®Google Scholar
• SfakianosJPChaEKIyerGGenomic characterization of upper tract urothelial carcinomaEur Urol201568697097726278805
   PubMed Web of Science ®Google Scholar
• MiyakeMGoodisonSRizwaniWRossSBart GrossmanHRosserCJUrinary BTA: indicator of bladder cancer or of hematuriaWorld J Urol201230686987322932760
   PubMed Web of Science ®Google Scholar
• MiyakeMGoodisonSGiacoiaEGRizwaniWRossSRosserCJInfluencing factors on the NMP-22 urine assay: an experimental modelBMC Urol20121212322928931
   PubMed Web of Science ®Google Scholar
• FantonyJJInmanBAIt may be time to abandon urine tests for bladder cancerJ Natl Compr Canc Netw20151391163116626358800
   PubMed Web of Science ®Google Scholar
• RobertsonAGKimJAl-AhmadieHComprehensive molecular characterization of muscle-invasive bladder cancerCell20181744103330096301
   PubMed Web of Science ®Google Scholar
• CowanNCTurneyBWTaylorNJMcCarthyCLCrewJPMultidetector computed tomography urography for diagnosing upper urinary tract urothelial tumourBJU Int20079961363137017428251
   PubMed Web of Science ®Google Scholar